| Dr Shannon Barry, AUD | |
|
5758 S Maryland Ave, Chicago, IL 60637-1426 | |
| (773) 702-1865 | |
| Not Available |
| Full Name | Dr Shannon Barry |
|---|---|
| Gender | Female |
| Speciality | Audiologist |
| Location | 5758 S Maryland Ave, Chicago, Illinois |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1457086407 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 231H00000X | Audiologist | 147.001888 (Illinois) | Primary |
| Provider Name | University Of Chicago |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1821048786 PECOS PAC ID: 7719899426 Enrollment ID: O20031103000094 |
News Archive
The chemotherapy worked as intended on cancer, extending the lifespan of mice injected with aggressive human tumors, reported a group led by Valter Longo of the University of Southern California.
Al Lewis, president of the Disease Management Purchasing Consortium, Inc., the founder and first president of the Disease Management Association of America and the person most often credited with establishing the metrics by which disease management is measured announced today that he will be personally validating and guaranteeing disease management (DM) and wellness outcomes for an elite, award-winning group of vendors, health plans, benefits consultants and employers.
Australian biotechnology company Biota Holdings revealed its US subsidiary has won a five year $US231 million ($A224.36 million) contract from the US government to develop a long-acting, single-dose flu drug for sale in the US. Shares in the Melbourne-based drug development company jumped 60 cents, or 57%, to $1.60 at the market open today falling back to $1.43, 1pm (AEST).
The first test to identify acute mountain sickness has been developed by a team of researchers in Italy and France and is presented today at EuroEcho-Imaging 2013. The test could revolutionise trekking and climbing by predicting who will develop the potentially deadly condition so they can avoid high altitudes, ascend more gradually or take preventative medication.
Covidien (NYSE: COV), a leading global provider of healthcare products, supports the U.S. Food and Drug Administration's Risk Evaluation and Mitigation Strategy (REMS) for an important class of pain medications.
› Verified 8 days ago
| Provider Name | The University Of Chicago Medical Center |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1033218128 PECOS PAC ID: 7618880766 Enrollment ID: O20031106000203 |
News Archive
The chemotherapy worked as intended on cancer, extending the lifespan of mice injected with aggressive human tumors, reported a group led by Valter Longo of the University of Southern California.
Al Lewis, president of the Disease Management Purchasing Consortium, Inc., the founder and first president of the Disease Management Association of America and the person most often credited with establishing the metrics by which disease management is measured announced today that he will be personally validating and guaranteeing disease management (DM) and wellness outcomes for an elite, award-winning group of vendors, health plans, benefits consultants and employers.
Australian biotechnology company Biota Holdings revealed its US subsidiary has won a five year $US231 million ($A224.36 million) contract from the US government to develop a long-acting, single-dose flu drug for sale in the US. Shares in the Melbourne-based drug development company jumped 60 cents, or 57%, to $1.60 at the market open today falling back to $1.43, 1pm (AEST).
The first test to identify acute mountain sickness has been developed by a team of researchers in Italy and France and is presented today at EuroEcho-Imaging 2013. The test could revolutionise trekking and climbing by predicting who will develop the potentially deadly condition so they can avoid high altitudes, ascend more gradually or take preventative medication.
Covidien (NYSE: COV), a leading global provider of healthcare products, supports the U.S. Food and Drug Administration's Risk Evaluation and Mitigation Strategy (REMS) for an important class of pain medications.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Shannon Barry, AUD 5758 S Maryland Ave, Chicago, IL 60637-1426 Ph: (773) 702-1865 | Dr Shannon Barry, AUD 5758 S Maryland Ave, Chicago, IL 60637-1426 Ph: (773) 702-1865 |
News Archive
The chemotherapy worked as intended on cancer, extending the lifespan of mice injected with aggressive human tumors, reported a group led by Valter Longo of the University of Southern California.
Al Lewis, president of the Disease Management Purchasing Consortium, Inc., the founder and first president of the Disease Management Association of America and the person most often credited with establishing the metrics by which disease management is measured announced today that he will be personally validating and guaranteeing disease management (DM) and wellness outcomes for an elite, award-winning group of vendors, health plans, benefits consultants and employers.
Australian biotechnology company Biota Holdings revealed its US subsidiary has won a five year $US231 million ($A224.36 million) contract from the US government to develop a long-acting, single-dose flu drug for sale in the US. Shares in the Melbourne-based drug development company jumped 60 cents, or 57%, to $1.60 at the market open today falling back to $1.43, 1pm (AEST).
The first test to identify acute mountain sickness has been developed by a team of researchers in Italy and France and is presented today at EuroEcho-Imaging 2013. The test could revolutionise trekking and climbing by predicting who will develop the potentially deadly condition so they can avoid high altitudes, ascend more gradually or take preventative medication.
Covidien (NYSE: COV), a leading global provider of healthcare products, supports the U.S. Food and Drug Administration's Risk Evaluation and Mitigation Strategy (REMS) for an important class of pain medications.
› Verified 8 days ago
Dr. Michael Santucci, Audiologist Medicare: Not Enrolled in Medicare Practice Location: 660 N Milwaukee Ave, Chicago, IL 60642 Phone: 312-432-1714 | |
Glasenhardt Av, Inc. Audiologist Medicare: Medicare Enrolled Practice Location: 5015 N Paulina St Ste 214, Chicago, IL 60640 Phone: 847-769-3948 | |
Dr. Katrina I Brow, AU.D. Audiologist Medicare: Not Enrolled in Medicare Practice Location: 111 N Wabash Ave, Suite 1618, Chicago, IL 60602 Phone: 312-251-0100 Fax: 312-251-0123 | |
Dr. Audrey Kay Cameron, AU.D. Audiologist Medicare: Not Enrolled in Medicare Practice Location: 7435 W Talcott Ave, Chicago, IL 60631 Phone: 773-792-5258 Fax: 773-792-9774 | |
Ms. Amy Kristeen Winston, AU.D. Audiologist Medicare: Accepting Medicare Assignments Practice Location: 1750 W Harrison St, 203 Senn, Chicago, IL 60612 Phone: 312-942-5332 Fax: 312-942-7068 | |
Kristen Marie Cortese, AU.D. Audiologist Medicare: Not Enrolled in Medicare Practice Location: 225 E Chicago Ave, Chicago, IL 60611 Phone: 312-227-3068 Fax: 312-227-9425 | |
Eric C Seper, Audiologist Medicare: Accepting Medicare Assignments Practice Location: 5841 S Maryland Ave, Chicago, IL 60637 Phone: 888-824-0200 |